Trexquant Investment’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,397
| Closed | -$447K | – | 1911 |
|
|
2024
Q4 | $447K | Sell |
11,397
-5,510
| -33% | -$216K | 0.01% | 1313 |
|
|
2024
Q3 | $666K | Sell |
16,907
-23,940
| -59% | -$943K | 0.01% | 1180 |
|
|
2024
Q2 | $1.59M | Sell |
40,847
-6,027
| -13% | -$235K | 0.02% | 828 |
|
|
2024
Q1 | $2.02M | Buy |
+46,874
| New | +$2.02M | 0.04% | 647 |
|
|
2023
Q3 | – | Sell |
-7,446
| Closed | -$287K | – | 1882 |
|
|
2023
Q2 | $287K | Buy |
+7,446
| New | +$287K | 0.01% | 1212 |
|
|
2021
Q4 | – | Sell |
-23,213
| Closed | -$355K | – | 1667 |
|
|
2021
Q3 | $355K | Buy |
+23,213
| New | +$355K | 0.03% | 670 |
|
|
2020
Q2 | – | Sell |
-31,793
| Closed | -$361K | – | 1538 |
|
|
2020
Q1 | $361K | Buy |
+31,793
| New | +$361K | 0.03% | 781 |
|
|
2019
Q1 | – | Sell |
-30,810
| Closed | -$194K | – | 1361 |
|
|
2018
Q4 | $194K | Buy |
30,810
+19,612
| +175% | +$123K | 0.01% | 922 |
|
|
2018
Q3 | $148K | Buy |
+11,198
| New | +$148K | 0.01% | 866 |
|